387 related articles for article (PubMed ID: 31701199)
1. Positioning time in range in diabetes management.
Advani A
Diabetologia; 2020 Feb; 63(2):242-252. PubMed ID: 31701199
[TBL] [Abstract][Full Text] [Related]
2. Glycaemia in low-premixed insulin analogue type 2 diabetes patients in a real-world setting: are the CGM targets met?
Krajnc M; Kravos Tramšek NA
Eur J Med Res; 2023 Mar; 28(1):111. PubMed ID: 36882852
[TBL] [Abstract][Full Text] [Related]
3. Continuous glucose monitoring targets in type 1 diabetes pregnancy: every 5% time in range matters.
Murphy HR
Diabetologia; 2019 Jul; 62(7):1123-1128. PubMed ID: 31161344
[TBL] [Abstract][Full Text] [Related]
4. Continuous glucose monitoring metrics (Mean Glucose, time above range and time in range) are superior to glycated haemoglobin for assessment of therapeutic efficacy.
Rodbard D
Diabetes Obes Metab; 2023 Feb; 25(2):596-601. PubMed ID: 36314133
[TBL] [Abstract][Full Text] [Related]
5. Individualization of recommendations from the international consensus on continuous glucose monitoring-derived metrics in Japanese children and adolescents with type 1 diabetes.
Urakami T; Yoshida K; Kuwabara R; Mine Y; Aoki M; Suzuki J; Morioka I
Endocr J; 2020 Oct; 67(10):1055-1062. PubMed ID: 32565500
[TBL] [Abstract][Full Text] [Related]
6. Application of medium-term metrics for assessing glucose homoeostasis: Usefulness, strengths and weaknesses.
Monnier L; Colette C; Owens D
Diabetes Metab; 2021 Mar; 47(2):101173. PubMed ID: 32561428
[TBL] [Abstract][Full Text] [Related]
7. Glucose Targets Using Continuous Glucose Monitoring Metrics in Older Adults With Diabetes: Are We There Yet?
Toschi E; O'Neal D; Munshi M; Jenkins A
J Diabetes Sci Technol; 2024 Jul; 18(4):808-818. PubMed ID: 38715259
[TBL] [Abstract][Full Text] [Related]
8. Associations between daily step count classifications and continuous glucose monitoring metrics in adults with type 1 diabetes: analysis of the Type 1 Diabetes Exercise Initiative (T1DEXI) cohort.
Turner LV; Marak MC; Gal RL; Calhoun P; Li Z; Jacobs PG; Clements MA; Martin CK; Doyle FJ; Patton SR; Castle JR; Gillingham MB; Beck RW; Rickels MR; Riddell MC;
Diabetologia; 2024 Jun; 67(6):1009-1022. PubMed ID: 38502241
[TBL] [Abstract][Full Text] [Related]
9. Effect of divergent continuous glucose monitoring technologies on glycaemic control in type 1 diabetes mellitus: A systematic review and meta-analysis of randomised controlled trials.
Elbalshy M; Haszard J; Smith H; Kuroko S; Galland B; Oliver N; Shah V; de Bock MI; Wheeler BJ
Diabet Med; 2022 Aug; 39(8):e14854. PubMed ID: 35441743
[TBL] [Abstract][Full Text] [Related]
10. Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials.
Maiorino MI; Signoriello S; Maio A; Chiodini P; Bellastella G; Scappaticcio L; Longo M; Giugliano D; Esposito K
Diabetes Care; 2020 May; 43(5):1146-1156. PubMed ID: 32312858
[TBL] [Abstract][Full Text] [Related]
11. Relationship of continuous glucose monitoring-related metrics with HbA1c and residual β-cell function in Japanese patients with type 1 diabetes.
Babaya N; Noso S; Hiromine Y; Taketomo Y; Niwano F; Yoshida S; Yasutake S; Kawabata Y; Ikegami H
Sci Rep; 2021 Feb; 11(1):4006. PubMed ID: 33597626
[TBL] [Abstract][Full Text] [Related]
12. Characterising frailty, metrics of continuous glucose monitoring, and mortality hazards in older adults with type 2 diabetes on insulin therapy (HARE): a prospective, observational cohort study.
Fung E; Lui LT; Huang L; Cheng KF; Lau GHW; Chung YT; Ahmadabadi BN; Xie S; Lee JSW; Hui E; So WY; Sung JJY; King I; Goggins WB; Chan Q; Järvelin MR; Ma RCW; Chow E; Kwok T
Lancet Healthy Longev; 2021 Nov; 2(11):e724-e735. PubMed ID: 36098029
[TBL] [Abstract][Full Text] [Related]
13. The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes.
Vigersky RA; McMahon C
Diabetes Technol Ther; 2019 Feb; 21(2):81-85. PubMed ID: 30575414
[TBL] [Abstract][Full Text] [Related]
14. The Importance of Continuous Glucose Monitoring-derived Metrics Beyond HbA1c for Optimal Individualized Glycemic Control.
Yoshii H; Mita T; Katakami N; Okada Y; Osonoi T; Aso K; Kurozumi A; Wakasugi S; Sato F; Ishii R; Gosho M; Shimomura I; Watada H
J Clin Endocrinol Metab; 2022 Sep; 107(10):e3990-e4003. PubMed ID: 35908248
[TBL] [Abstract][Full Text] [Related]
15. Effect of insulin degludec versus insulin glargine U100 on time in range: SWITCH PRO, a crossover study of basal insulin-treated adults with type 2 diabetes and risk factors for hypoglycaemia.
Goldenberg RM; Aroda VR; Billings LK; Christiansen ASL; Meller Donatsky A; Parvaresh Rizi E; Podgorski G; Raslova K; Klonoff DC; Bergenstal RM
Diabetes Obes Metab; 2021 Nov; 23(11):2572-2581. PubMed ID: 34322967
[TBL] [Abstract][Full Text] [Related]
16. DYNAMIC: Dynamic glucose management strategies delivered through a structured education program improves time in range in a socioeconomically deprived cohort of children and young people with type 1 diabetes with a history of hypoglycemia.
Pemberton JS; Kershaw M; Dias R; Idkowiak J; Mohamed Z; Saraff V; Barrett TG; Krone R; Uday S
Pediatr Diabetes; 2021 Mar; 22(2):249-260. PubMed ID: 33205572
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of self-monitoring of blood glucose versus retrospective continuous glucose monitoring in improving glycaemic control in diabetic kidney disease patients.
Yeoh E; Lim BK; Fun S; Tong J; Yeoh LY; Sum CF; Subramaniam T; Lim SC
Nephrology (Carlton); 2018 Mar; 23(3):264-268. PubMed ID: 27933715
[TBL] [Abstract][Full Text] [Related]
18. Time-in-range for monitoring glucose control: Is it time for a change?
Bellido V; Pinés-Corrales PJ; Villar-Taibo R; Ampudia-Blasco FJ
Diabetes Res Clin Pract; 2021 Jul; 177():108917. PubMed ID: 34126129
[TBL] [Abstract][Full Text] [Related]
19. Relationship between key continuous glucose monitoring-derived metrics and specific cognitive domains in patients with type 2 diabetes mellitus.
Dong S; Wang L; Zhao C; Zhang R; Gao Z; Jiang L; Guo Y; Zhou H; Xu S
BMC Neurol; 2023 May; 23(1):200. PubMed ID: 37210479
[TBL] [Abstract][Full Text] [Related]
20. An Assessment of Clinical Continuous Glucose Monitoring Targets for Older and High-Risk People Living with Type 1 Diabetes.
O'Neal DN; Cohen O; Vogrin S; Vigersky RA; Jenkins AJ;
Diabetes Technol Ther; 2023 Feb; 25(2):108-115. PubMed ID: 36315189
[No Abstract] [Full Text] [Related]
[Next] [New Search]
